SILAC-Based Quantitative Proteomics Identifies Multifactorial Mechanism of Oxaliplatin Resistance in Pancreatic Cancer Cells
Y. E. Kim, E.-K. Kim, M.-J. Song, T.-Y. Kim, H. H. Jang, D. Kang
This study uses SILAC-based proteomics to identify proteins involved in oxaliplatin resistance in pancreatic cancer cells, finding that MARCKS and WLS contribute to resistance through AKT and β-catenin signaling.
bioRxiv · Sep 4, 2020 · PreprintCancer Biology